A gene signature associated with alpha-linolenic acid metabolism predicts clinical prognosis in hepatocellular carcinoma

This study provides a comprehensive analysis of ALA metabolism-associated genes in HCC and proposes a novel risk-based prognostic framework. The developed model demonstrates strong predictive performance for patient survival outcomes, representing the first such approach with robust validation in forecasting prognosis in HCC.